Eli Lilly

The new site will primarily focus on manufacturing medications and distributing them to patients. Lilly officials say the facility will allow them to make new medicines "more efficiently" and with "greener methods."

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the approval of the drug on Thursday.

Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and toward synthetic genetically engineered alternatives.

This latest expansion brings Lilly’s totaled pledge investment at the site to more than $13 billion and potentially 1,300 jobs.

Eli Lilly will more than double its investment at its manufacturing plant in Lebanon to make more of its popular weight loss drugs.

Novo Nordisk along with Sanofi and Indianapolis-based Eli Lilly control over 90 percent of the world insulin market.

Indiana manufacturers want to continue to use certain types of toxic PFAS. A state House bill, HB 1399, aims to change the definition of PFAS under Indiana law to exclude the specific chemicals they want to use.

Eli Lilly announced Thursday a new telehealth service for patients with diabetes, migraines and obesity.

Officials with Eli Lilly said the new facility will help them produce state-of-the-art drugs – including the company's new diabetes and obesity drug, Mounjaro.

The company’s Humalog and Humalin insulins will have a 70 percent price cut later this year. Its non-branded insulin will also receive a price cut.